Anaesthetic drugs: Linking molecular actions to clinical effects

Current Pharmaceutical Design

Volumn 12, Issue 28, 2006, Pages 3665-3679

  Grasshoff, Christian ^a   Drexler, Berthold ^a   Rudolph, Uwe ^b   Antkowiak, Bernd ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Immobility; Ligand gated ion channels; Meyer Overton correlation; NMDA receptors; Sedation; Synaptic transmission

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANESTHETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; ENFLURANE; ETOMIDATE; GLUTAMATE RECEPTOR; GLYCINE RECEPTOR; HALOTHANE; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; ION CHANNEL; ISOFLURANE; KETAMINE; MIDAZOLAM; MUSCLE RELAXANT AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITROUS OXIDE; OPIATE; POTASSIUM CHANNEL; PROPOFOL; SEVOFLURANE;

AMNESIA; ANALGESIA; BINDING SITE; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; DRUG TARGETING; DRUG USE; GENERAL ANESTHESIA; HUMAN; HYPNOSIS; HYPOTHERMIA; IMMOBILIZATION; MOLECULAR DYNAMICS; NONHUMAN; PHARMACOLOGICAL BLOCKING; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; RESPIRATION DEPRESSION; REVIEW; SEDATION; SPINAL CORD; SYNAPTIC TRANSMISSION;

ANESTHETICS; BINDING SITES; HUMANS; PROTEIN BINDING;

EID: 33749441324     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206778522038     Document Type: Review

References (159)

1. Wiklund RA, Rosenbaum SH. Anesthesiology. First of two parts. N Engl J Med 1997; 337: 1132-41.
2. Campagna JA, Miller KW, Forman SA. Mechanisms of actions of inhaled anesthetics. N Engl J Med 2003; 348: 2110-24.
3. Urban BW, Bleckwenn M. Concepts and correlations relevant to general anaesthesia. Br J Anaesth 2002; 89: 3-16.
4. Tonner PH. Drug development in anaesthesia: go create! Curr Opin Anaesthesiol 2005; 16: 383-5.
5. Meyer H. Welche Eigenschaft der Anästhetica bedingt ihre narkotische Wirkung? Arch Exp Pathol Pharmakol (Naunyn-Schmiedebergs) 1899; 42: 109-18.
6. Overton E. Studien über die Narkose, zugleich ein Beitrag zur allgemeinen Pharmakologie. Jena, Gustav Fischer 1901.
7. Urban BW. Current assessment of targets and theories of anaesthesia. Br J Anaesth 2002; 89: 165-83.
8. Franks NP, Lieb WR. Do general anaesthetics act by competitive binding to specific receptors? Nature 1984; 310: 599-601.
9. Franks NP, Lieb WR. Stereospecific effects of inhalational general anesthetic optical isomeres on nerve ion channels. Science 1991; 254: 427-30.
10. Belelli D, Muntoni AL, Merrywest SD, Gentet LJ, Casula A, Callachan H, et al. The in vitro and in vivo enantioselectivity of etomidate implicates the GABAA receptor in general anaesthesia. Neuropharmacology 2003; 45: 57-71.
11. Franks NP, Lieb WR. Molecular mechanisms of general anaesthesia. Nature 1982; 300: 487-93.
12. Koblin DD, Chortkoff BS, Laster MJ, Eger II EI, Halsey MJ, Ionescu P. Polyhalogenated and perfluorinated compounds that disobey the Meyer-Overton hypothesis. Anesth Analg 1994; 79: 1043-8.
13. Rudolph U, Antkowiak B. Molecular and neuronal substrates for general anaesthetics. Nat Rev Neurosci 2004; 5: 709-20.
14. Liu R, Eckenhoff RG. Weak polar interactions confer albumin binding site selectivity for haloether anesthetics. Anesthesiology 2005; 102: 799-805.
15. A receptor/chloride channel complex in anesthesia. Anesthesiology 1993; 78: 757-76.
16. - current correlates with in vivo anesthetic potency. J Pharmacol Exp Ther 1994; 270: 987-91.
17. Jurd R, Arras M, Lambert S, Drexler B, Siegwart R, Crestani F, et al. General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta 3 subunit. FASEB J 2003; 17: 250-2.
18. A receptor channels. Annu Rev Neurosci 1994; 17: 569-602.
19. Bormann J. The 'ABC' of GABA receptors. Trends Pharmacol Sci 2000; 21: 16-9.
20. Whiting PJ. GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery? Drug Discov Today 2003; 8: 445-50.
21. Fritschy JM, Brunig I. Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol Ther 2003; 98: 299-323.
22. Sieghart W, Sperk G. Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem 2002; 2: 795-816.
23. Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors. Nat Rev Neurosci 2005; 6: 215-29.
24. Mody I, Pearce RA. Diversity of inhibitory neurotransmission through GABA(A) receptors. Trends Neurosci 2004; 27: 569-75.
25. Ernst M, Brauchart D, Boresch S, Sieghart W. Comparative modeling of GABA(A) receptors: limits, insights, future developments. Neuroscience 2003: 119: 933-43.
26. - ion channels modulated by multiple drug-binding sites. Trends Pharmacol Sci 1992; 13: 446-50.
27. Boileau AJ, Evers AR, Davis AF, Czajkowski C. Mapping the agonist binding site of the GABAA receptor: evidence for a beta-strand. J Neurosci 1999; 19: 4847-54.
28. Teissere JA, Czajkowski C. A (beta)-strand in the (gamma)2 subunit lines the benzodiazepine binding site of the GABA A receptor: structural rearrangements detected during channel gating. J Neurosci 2001; 21: 4977-86.
29. Sigel E. Mapping of the benzodiazepine recognition site on GABA(A) receptors. Curr Top Med Chem 2002; 2: 833-9.
30. Kash TL, Trudell JR, Harrison NL. Structural elements involved in activation of the gamma-aminobutyric acid type A (GABAA) receptor. Biochem Soc Trans 2004; 32: 540-6.
31. Wagner DA, Czajkowski C, Jones MV. An arginine involved in GABA binding and unbinding but not gating of the GABA(A) receptor. J Neurosci 2004; 24: 2733-41.
32. Wagner DA, Czajkowski C. Structure and dynamics of the GABA binding pocket: A narrowing cleft that constricts during activation. J Neurosci 2001; 21: 67-74.
33. Kash TL, Jenkins A, Kelley JC, Trudell JR, Harrison NL. Coupling of agonist binding to channel gating in the GABA(A) receptor. Nature 2003; 421: 272-5.
34. Antkowiak B. How do general anaesthetics work? Naturwissenschaften 2001; 88: 201-13.
35. Möhler H, Fritschy JM, Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther 2002; 300: 2-8.
36. A receptors. Trends Pharmacol Sci 1995; 16: 162-8.
37. Rogers CJ, Twyman RE, Macdonald RL. Benzodiazepine and beta-carboline regulation of single GABAA receptor channels of mouse spinal neurones in culture. J Physiol 1994; 475: 69-82.
38. Rusch D, Forman SA. Classic benzodiazepines modulate the open-close equilibrium in alpha1beta2gamma2L gamma-aminobutyric acid type A receptors. Anesthesiology 2005; 102: 783-92.
39. Downing SS, Lee YT, Farb DH, Gibbs TT. Benzodiazepine modulation of partial agonist efficacy and spontaneously active GABA(A) receptors supports an allosteric model of modulation. Br J Pharmacol 2005; 145: 894-906.
40. Mody I, Tanelian DL, MacIver MB. Halothane enhances tonic neuronal inhibition by elevating intracellular calcium. Brain Res 1991; 538: 319-23.
41. A receptors in cultured murine hippocampal neurons. J Neurosci 1994; 14: 7747-60.
42. A IPSCs: Dissociation of blocking and prolonging effects. Anesthesiology 1999; 90: 120-34.
43. Verbny YI, Merriam EB, Banks MI. Modulation of gamma-Aminobutyric Acid Type A Receptor-mediated Spontaneous Inhibitory Postsynaptic Currents in Auditory Cortex by Midazolam and Isoflurane. Anesthesiology 2005; 102: 962-9.
44. Belelli D, Pistis I, Peters JA, Lambert JJ. General anaesthetic action at transmitter-gated inhibitory amino acid receptors. Trends Pharmacol Sci 1999; 20: 496-502.
45. A and glycine receptors. Nature 1997; 389: 385-9.
46. Belelli D, Lambert JJ, Peters JA, Wafford K, Whiting PJ. The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid. Proc Natl Acad Sci USA 1997; 94: 11031-6.
47. 2 receptors. J Neurochem 2002; 80: 140-8.
48. Krasowski MD, Koltchine VV, Rick CE, Ye Q, Finn SE, Harrison NL. Propofol and other intravenous anesthetics have sites of action on the gamma-aminobutyric acid type A receptor distinct from that of isoflurane. Mol Pharmacol 1998; 53: 530-8.
49. Jenkins A, Greenblatt EP, Faulkner HJ, Bertaccini E, Light A, Lin A, et al. Evidence for a common binding cavity for three general anesthetics within the GABAA receptor. J Neurosci 2001; 21: RC136.
50. Jenkins A, Andreasen A, Trudell JR, Harrison NL. Tryptophan scanning mutagenesis in TM4 of the GABA(A) receptor alpha1 subunit: implications for modulation by inhaled anesthetics and ion channel structure. Neuropharmacology 2002; 43: 669-78.
51. Nishikawa K, Harrison NL. The actions of sevoflurane and desflurane on the gamma-aminobutyric acid receptor type A: effects of TM2 mutations in the alpha and beta subunits. Anesthesiology 2003; 99: 678-84.
52. Rusch D, Zhong H, Forman SA. Gating allosterism at a single class of etomidate sites on alpha1beta2gamma2L GABA A receptors accounts for both direct activation and agonist modulation. J Biol Chem 2004; 279: 20982-92.
53. Antkowiak B, Heck D. Effects of the volatile anesthetic enflurane on spontaneous discharge rate and GABA(A)-mediated inhibition of Purkinje cells in rat cerebellar slices. J Neurophysiol 1997; 77: 2525-38.
54. Urban BW. Differential effects of gaseous and volatile anaesthetics on sodium and potassium channels. Br J Anaesth 1993; 71: 25-38.
55. Dilger JP. The effects of general anaesthetics on ligand-gated ion channels. Br J Anaesth 2002; 89: 41-51.
56. Cherubini E, Conti F. Generating diversity at GABAergic synapses. Trends Neurosci 2001; 24: 155-62.
57. Mody I, De Koninck Y, Otis TS, Soltesz I. Bridging the cleft at GABA synapses in the brain. Trends Neurosci 1994; 17: 517-25.
58. Clements JD. Transmitter timecourse in the synaptic cleft: its role in central synaptic function. Trends Neurosci 1996; 19: 163-71.
59. Li X, Czajkowski C, Pearce RA. Rapid and direct modulation of GABAA receptors by halothane. Anesthesiology 2000; 92: 1366-75.
60. A receptor kinetics: evidence for slowed agonist unbinding. J Neurosci 2000; 20: 899-907.
61. Topf N, Jenkins A, Baron N, Harrison NL. Effects of isoflurane on gamma-aminobutyric acid type A receptors activated by full and partial agonists. Anesthesiology 2003; 98: 306-11.
62. A receptor desensitization. Toxicol Lett 1998; 100: 217-24.
63. Franks NP, Lieb WR. Which molecular targets are most relevant to general anaesthesia? Toxicol Lett 1998; 100-101: 1-8.
64. Eckenhoff RG, Johansson JS. On the relevance of "clinically relevant concentrations" of inhaled anesthetics in in vitro experiments. Anesthesiology 1999; 91: 856-60.
65. Eckenhoff RG, Johansson JS. What are "relevant" concentrations? Anesthesiology 2001; 95: 1537-9.
66. Eger II EI, Fisher DM, Dilger JP, Sonner JM, Evers A, Franks NP, et al. Relevant concentrations of inhaled anesthetics for in vitro studies of anesthetic mechanisms. Anesthesiology 2001; 94: 915-21.
67. Eckenhoff MF, Chan K, Eckenhoff RG. Multiple specific binding targets for inhaled anesthetics in the mammalian brain. J Pharmacol Exp Ther 2002; 300: 172-9.
68. Franks NP, Lieb WR. Selective actions of volatile general anaesthetics at molecular and cellular levels. Br J Anaesth 1993; 71: 65-76.
69. Rehberg B, Xiao YH, Duch DS. Central nervous system sodium channels are significantly suppressed at clinical concentrations of volatile anesthetics. Anesthesiology 1996; 84: 1223-33.
70. Krasowski MD, Harrison NL. General anaesthetic actions on ligand-gated ion channels. Cell Mol Life Sci 1999; 55: 1278-303.
71. Yamakura T, Harris RA. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology 2000; 93: 1095-101.
72. Yamamura T, Harada K, Okamura A, Kemmotsu O. Is the site of action of ketamine anesthesia the N-methyl-D-aspartate receptor? Anesthesiology 1990; 72: 704-10.
73. Orser BA, Pennefather PS, MacDonald JF. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors. Anesthesiology 1997; 86: 903-17.
74. Jevtovic-Todorovic V, Todorovic SM, Mennerick S, Powell S, Dikranian K, Benshoff N, et al. Nitrous oxide (Laughing gas) is a NMDA antagonist, neuroprotectant and neurotoxin. Nature Med 1998; 4: 460-3.
75. Mennerick S, Jevtovic-Todorovic V, Todorovic SM, Shen W, Olney JW, Zorumski CF. Effects of Nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci 1998; 18: 9716-26.
76. Lowry DW, Mirakhur RK, McCarthy GJ, Carroll MT, McCourt KC. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia. Anesth Analg 1998; 87: 936-40.
77. Motamed C, Donati F. Sevoflurane and isoflurane, but not propofol, decrease mivacurium requirements over time. Can J Anaesth 2002; 49: 907-12.
78. Matute E, Rivera-Arconada I, Lopez-Garcia JA. Effects of propofol and sevoflurane on the excitability of rat spinal motoneurones and nociceptive reflexes in vitro. Br J Anaesth 2004; 93: 422-7.
79. Kendig JJ. Spinal cord as a site of anesthetic action. Anesthesiology 1993; 79: 1161-2.
80. Eger II EI, Koblin DD, Harris RA, Kendig JJ, Pohorille A, Halsey MJ, et al. Hypothesis: Inhaled anesthetics produce immobility and amnesia by different mechanisms at different sites. Anesth Analg 1997; 84: 915-8.
81. Kissin I. A concept for assessing interactions of general anesthetics. Anesth Analg 1997; 85: 204-10.
82. Rudolph U, Mohler H. Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics. Annu Rev Pharmacol Toxicol 2004; 44: 475-98.
83. Sonner JM, Zhang Y, Stabernack C, Abaigar W, Xing Y, Laster MJ. GABA(A) receptor blockade antagonizes the immobilizing action of propofol but not ketamine or isoflurane in a dose-related manner. Anesth Analg 2003; 96: 706-12.
84. Reynolds DS, Rosahl TW, Cirone J, O'Meara GF, Haythornthwaite A, Newman RJ, et al. Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms. J Neurosci 2003; 23: 8608-17.
85. Wisden W, Gundlach AL, Barnard EA, Seeburg PH, Hunt SP. Distribution of GABAA receptor subunit mRNAs in rat lumbar spinal cord. Brain Res Mol Brain Res 1991; 10: 179-83.
86. Bohlhalter S, Weinmann O, Mohler H, Fritschy JM. Laminar compartmentalization of GABAA-receptor subtypes in the spinal cord: an immunohistochemical study. J Neurosci 1996; 16: 283-97.
87. Crestani F, Low K, Keist R, Mandelli M, Mohler H, Rudolph U. Molecular targets for the myorelaxant action of diazepam. Mol Pharmacol 2001; 59: 442-5.
88. Sonner JM, Antognini JF, Dutton RC, Flood P, Gray AT, Harris RA, et al. Inhaled anesthetics and immobility: mechanisms, mysteries, and minimum alveolar anesthetic concentration. Anesth Analg 2003; 97: 718-40.
89. Lambert S, Arras M, Vogt KE, Rudolph U. Isoflurane-induced surgical tolerance mediated only in part by beta3-containing GABA(A) receptors. Eur J Pharmacol 2005; 516: 23-7.
90. Liao M, Sonner JM, Jurd R, Rudolph U, Borghese CM, Harris RA, et al. Beta3-containing gamma-aminobutyric acidA receptors are not major targets for the amnesic and immobilizing actions of isoflurane. Anesth Analg 2005; 101: 412-8.
91. Heurteaux C, Guy N, Laigle C, Blondeau N, Duprat F, Mazzuca M, et al: TREK-1, a K(+) channel involved in neuroprotection and general anesthesia. EMBO J 2004; 23: 2684-95.
92. Zhang Y, Laster MJ, Hara K, Harris RA, Eger EI, Stabernack CR, et al. Glycine receptors mediate part of the immobility produced by inhaled anesthetics. Anesth Analg 2003; 96: 97-101.
93. Grasshoff C, Antkowiak B. Propofol and sevoflurane depress spinal neurons in vitro via different molecular targets. Anesthesiology 2004; 101: 1167-76.
94. Cheng G, Kendig JJ. Enflurane decreases glutamate neurotransmission to spinal cord motor neurons by both pre- and postsynaptic actions. Anesth Analg 2003; 96: 1354-9.
95. Ishizaki K, Yoon DM, Yoshida N, Yamazaki M, Arai K, Fujita T. Intrathecal administration of N-methyl-D-aspartate receptor antagonist reduces the minimum alveolar anaesthetic concentration of isoflurane in rats. Br J Anaesth 1995; 75: 636-8.
96. Hentschke H, Schwarz C, Antkowiak B. Neocortex is the major target of sedative concentrations of volatile anaesthetics: strong depression of firing rates and increase of GABAA receptor-mediated inhibition. Eur J Neurosci 2005; 21: 93-102.
97. Antkowiak B, Helfrich-Forster C. Effects of small concentrations of volatile anesthetics on action potential firing of neocortical neurons in vitro. Anesthesiology 1998; 88: 1592-605.
98. Antkowiak B. Different actions of general anesthetics on the firing patterns of neocortical neurons mediated by the GABA(A) receptor. Anesthesiology 1999; 91: 500-11.
99. Heinke W, Fiebach CJ, Schwarzbauer C, Meyer M, Olthoff D, Alter K. Sequential effects of propofol on functional brain activation induced by auditory language processing: an event-related functional magnetic resonance imaging study. Br J Anaesth 2004; 92: 641-50.
100. Rudolph U, Crestani F, Benke D, Brunig I, Benson JA, Fritschy JM et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 1999; 401: 796-800.
101. Drexler B, Roether CL, Jurd R, Rudolph U, Antkowiak B. Opposing actions of etomidate on cortical theta oscillations are mediated by different gamma-aminobutyric acid type A receptor subtypes. Anesthesiology 2005; 102: 346-52.
102. Merriam EB, Netoff TI, Banks MI. Bistable network behavior of layer I interneurons in auditory cortex. J Neurosci 2005; 25: 6175-86.
103. Huntsman MM, Porcello DM, Homanics GE, DeLorey TM, Huguenard JR. Reciprocal inhibitory connections and network synchrony in the mammalian thalamus. Science 1999; 283: 541-3.
104. Koht A, Schütz W, Schmidt G, Schramm J, Watanabe E. Effects of etomidate, midazolam, and thiopental on median nerve somatosensory evoked potentials and the additive effects of fentanyl and nitrous oxide. Anesth Analg 1988; 67: 441.
105. Angel A, Arnott RH. The effect of etomidate on sensory transmission in the dorsal column pathway in the urethane-anaesthetized rat. Eur J Neurosci 1999; 11: 2497-505.
106. Ying SW, Goldstein PA. Propofol-block of SK channels in reticular thalamic neurons enhances GABAergic inhibition in relay neurons. J Neurophysiol 2005; 93: 1935-48.
107. Pasternak T, Greenlee MW. Working memory in primate sensory systems. Nat Rev Neurosci 2005; 6: 97-107.
108. Gajraj RJ, Doi M, Mantzaridis H, Kenny GN. Analysis of the EEG bispectrum, auditory evoked potentials and the EEG power spectrum during repeated transitions from consciousness to unconsciousness. Br J Anaesth 1998; 80: 46-52.
109. Corkin S. What's new with the amnesic patient H.M.? Nat Rev Neurosci 2002; 3: 153-60.
110. Sur C, Fresu L, Howell O, McKernan RM, Atack JR. Autoradiographic localization of alpha5 subunit-containing GABAA receptors in rat brain. Brain Res 1999; 822: 265-70.
111. Caraiscos VB, Newell JG, You T, Elliott EM, Rosahl TW, Wafford KA, et al. Selective enhancement of tonic GABAergic inhibition in murine hippocampal neurons by low concentrations of the volatile anesthetic isoflurane. J Neurosci 2004; 24: 8454-8.
112. Collinson N, Kuenzi FM, Jarolimek W, Maubach KA, Cothliff R, Sur C, et al. Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J Neurosci 2002; 22: 5572-80.
113. Crestani F, Keist R, Fritschy JM, Benke D, Vogt K, Prut L, et al. Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors. Proc Natl Acad Sci USA 2002: 99: 8980-5.
114. Veselis RA, Reinsel RA, Feshchenko VA, Dnistrian AM. A neuroanatomical construct for the amnesic effects of propofol. Anesthesiology 2002; 97: 329-37.
115. Veselis RA, Reinsel RA, Feshchenko VA, Johnson R, Jr. Information loss over time defines the memory defect of propofol: a comparative response with thiopental and dexmedetomidine. Anesthesiology 2004; 101: 831-41.
116. Perouansky M, Pearce RA. Effects on synaptic inhibition in the hippocampus do not underlie the amnestic and convulsive properties of the nonimmobilizer 1, 2-dichlorohexafluorocyclobutane. Anesthesiology 2004; 101: 66-74.
117. Perouansky M, Banks MI, Pearce RA. The differential effects of the nonimmobilizer 1, 2-dichlorohexafluorocyclobutane (F6, 2N) and isoflurane on extrasynaptic gamma-aminobutyric acid A receptors. Anesth Analg 2005; 100: 1667-73.
118. Alkire MT, Vazdarjanova A, Dickinson-Anson H, White NS, Cahill L. Lesions of the basolateral amygdala complex block propofol-induced amnesia for inhibitory avoidance learning in rats. Anesthesiology 2001; 95: 708-15.
119. Alkire MT, Nathan SV. Does the Amygdala Mediate Anesthetic-induced Amnesia?: Basolateral Amygdala Lesions Block Sevoflurane-induced Amnesia. Anesthesiology 2005; 102: 754-60.
120. Ranft A, Kurz J, Deuringer M, Haseneder R, Dodt HU, Zieglgansberger W, et al. Isoflurane modulates glutamatergic and GABAergic neurotransmission in the amygdala. Eur J Neurosci 2004; 20: 1276-80.
121. Löw K, Crestani F, Keist R, Benke D, Brünig I, Benson JA, et al. Molecular and neuronal substrate for the selectice attenuation of anxiety. Science 2000; 290: 131-4.
122. Royston D, Cox F. Anaesthesia: the patient's point of view. Lancet 2003; 362: 1648-58.
123. Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? The perspective of patients. Anesth Analg 1999; 89: 652-8.
124. Gan TJ, Meyer T, Apfel CC, Chung F, Davis PJ, Eubanks S, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97: 62-71.
125. Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology 1999; 91: 693-700.
126. Andrews PL. Physiology of nausea and vomiting. Br J Anaesth 1992; 69: 2S-19S.
127. Apfel CC, Kranke P, Katz MH, Goepfert C, Papenfuss T, Rauch S, et al. Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design. Br J Anaesth 2002; 88: 659-68.
128. Visser K, Hassink EA, Bonsel GJ, Moen J, Kalkman CJ. Randomized controlled trial of total intravenous anesthesia with propofol versus inhalation anesthesia with isoflurane-nitrous oxide: postoperative nausea with vomiting and economic analysis. Anesthesiology 2001; 95: 616-26.
129. Gupta A, Stierer T, Zuckerman R, Sakima N, Parker SD, Fleisher LA. Comparison of recovery profile after ambulatory anesthesia with propofol, isoflurane, sevoflurane and desflurane: a systematic review. Anesth Analg 2004; 98: 632-41.
130. Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, et al. A factorial trial of six interventions for the prevention of post-operative nausea and vomiting. N Engl J Med 2004; 350: 2441-51.
131. Stevens RJ, Rusch D, Davies PA, Raines DE. Molecular properties important for inhaled anesthetic action on human 5-HT3A receptors. Anesth Analg 2005; 100: 1696-703.
132. Suzuki T, Koyama H, Sugimoto M, Uchida I, Mashimo T. The diverse actions of volatile and gaseous anesthetics on human-cloned 5-hydroxytryptamine3 receptors expressed in Xenopus oocytes. Anesthesiology 2002; 96: 699-704.
133. Laer S, Scholz J, Ritterbach C, Laer C, Rahme E, Schulte am EJ. Association between increased 5-HIAA plasma concentrations and postoperative nausea and vomiting in patients undergoing general anaesthesia for surgery. Eur J Anaesthesiol 2001; 18: 833-5.
134. Borgeat A, Wilder-Smith OH, Saiah M, Rifat K. Subhypnotic doses of propofol possess direct antiemetic properties. Anesth Analg 1992; 74: 539-41.
135. De Witte J, Sessler DI. Perioperative shivering: physiology and pharmacology. Anesthesiology 2002; 96: 467-84.
136. Horn EP, Werner C, Sessler DI, Steinfath M, Schulte am EJ. Late intraoperative clonidine administration prevents postanesthetic shivering after total intravenous or volatile anesthesia. Anesth Analg 1997; 84: 613-7.
137. Frank SM, Fleisher LA, Breslow MJ, Higgins MS, Olson KF, Kelly S, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. A randomized clinical trial. JAMA 1997; 277: 1127-34.
138. Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A. Mild hypothermia increases blood loss and transfusion requirements during total hip arthroplasty. Lancet 1996; 347: 289-92.
139. Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996; 334: 1209-15.
140. Cirone J, Rosahl TW, Reynolds DS, Newman RJ, O'Meara GF, Hutson PH, et al. Gamma-aminobutyric acid type A receptor beta 2 subunit mediates the hypothermic effect of etomidate in mice. Anesthesiology 2004; 100: 1438-45.
141. Dal D, Kose A, Honca M, Akinci SB, Basgul E, Aypar U. Efficacy of prophylactic ketamine in preventing postoperative shivering. Br J Anaesth 2005; 95: 189-92.
142. Eger EI. New inhaled anesthetics. Anesthesiology 1994; 80: 906-22.
143. Kashiwagi M, Okada Y, Kuwana S, Sakuraba S, Ochiai R, Takeda J. A neuronal mechanism of propofol-induced central respiratory depression in newborn rats. Anesth Analg 2004; 99: 49-55.
144. White PF, Way WL, Trevor AJ. Ketamine - its pharmacology and therapeutic uses. Anesthesiology 1982; 56: 119-36.
145. Porter K. Ketamine in prehospital care. Emerg Med J 2004; 21: 351-4.
146. Stucke AG, Zuperku EJ, Krolo M, Brandes IF, Hopp FA, Kampine JP, et al. Sevoflurane enhances gamma-aminobutyric acid type A receptor function and overall inhibition of inspiratory premotor neurons in a decerebrate dog model. Anesthesiology 2005; 103: 57-64.
147. Stucke AG, Zuperku EJ, Tonkovic-Capin V, Krolo M, Hopp FA, Kampine JP, et al. Sevoflurane depresses glutamatergic neurotransmission to brainstem inspiratory premotor neurons but not postsynaptic receptor function in a decerebrate dog model. Anesthesiology 2005; 103: 50-6.
148. Zeller A, Arras M, Lazaris A, Jurd R, Rudolph U. Distinct molecular targets for the central respiratory and cardiac actions of the general anesthetics etomidate and propofol. FASEB J 2005; 19: 1677-9.
149. Lagasse RS. Anesthesia safety: model or myth? A review of the published literature and analysis of current original data. Anesthesiology 2002; 97: 1609-17.
150. Futterer CD, Maurer MH, Schmitt A, Feldmann RE Jr, Kuschinsky W, Waschke KF. Alterations in rat brain proteins after desflurane anesthesia. Anesthesiology 2004; 100: 302-8.
151. Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg 2005; 100: 4-10.
152. Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci 2003; 23: 876-82.
153. Todd MM. Anesthetic neurotoxicity: the collision between laboratory neuroscience and clinical medicine. Anesthesiology 2004; 101: 272-3.
154. Olney JW, Young C, Wozniak DF, Ikonomidou C, Jevtovic-Todorovic V. Anesthesia-induced developmental neuroapoptosis. Does it happen in humans? Anesthesiology 2004; 101: 273-5.
155. Ben Ari Y. Excitatory actions of gaba during development: the nature of the nurture. Nat Rev Neurosci 2002; 3: 728-39.
156. Ben Ari Y, Holmes GL. The multiple facets of gamma-aminobutyric acid dysfunction in epilepsy. Curr Opin Neurol 2005; 18: 141-5.
157. Fozzard HA, Lee PJ, Lipkind GM. Mechanism of local anesthetic drug action on voltage-gated sodium channels. Curr Pharm Des 2005; 11(21): 2671-86.
158. Kalso E. Sodium channel blockers in neuropathic pain. Curr Pharm Des 2005; 11(23): 3005-11.
159. Sabatowski R, Schafer D, Kasper SM, Brunsch H, Radbruch L. Pain treatment: a historical overview. Curr Pharm Des 2004; 10(7): 701-16.